SEC INSIDER TRANSACTIONS

BIO-TECHNE Corp (TECH) Insider Transactions

Explore official ownership filings, with every record linked to its source.

Reported data · not live

TECH · BIO-TECHNE Corp

Filing window SEC codes (comma separated) Security type Order

More transaction filters

Roles: director,officer,ten_percent_owner,otherOwner nameOfficer titleOwnership: D, I, unknownoriginal or amendedTransaction fromTransaction throughFiled fromFiled throughMinimum quantityMaximum quantityMinimum priceMaximum priceMinimum calculated valueMaximum calculated valueResults per page (1–100)

OR within codes/roles; AND between categories. Roles apply to buyers and sellers. Owner predicates match the same owner. Missing values fail numeric/date filters. Value is quantity × reported price for non-derivative rows only; derivative values are unknown. Amendments stay separate; joint owners do not duplicate rows.

Reset filters

Stale snapshot · Covered: filings 2026-10-15 to 2026-11-13 · 14 filings · fetched 2026-11-13T20:19:21Z

View six-calendar-month insider history →

Recent reported activity

0purchase rows on this page

0sale rows on this page

44matching filing rows

Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.

Transaction / filed	Reporting owner(s)	Code / security	Quantity	Price as filed	Ownership	Source
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F3, F4	M Exercise / conversionPerformance Restricted Stock Units · Derivative	683D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F2	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	23,949D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References: F1	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	22,044D	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	10,955D	72.4	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Kelderman KimDirector · Officer · Chief Executive Officer Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,837 performance options. The remainder of the performance options were forfeited. F2 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,996 performance options. The remainder of the performance options were forfeited. F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F4 On 8/15/2026, the Board of Directors authorized discretionary vesting for 683 performance RSUs. The remainder of the performance RSUs were forfeited. F5 On 8/15/2026, the Board of Directors authorized discretionary vesting for 725 performance RSUs. The remainder of the performance RSUs were forfeited. F6 8,543 restricted stock units vest on 8/15/2026, and 8,544 restricted stock units vest on 8/15/2027. F7 11,785 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 11,784 restricted stock units vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	21,736A	0	Direct	Form 4/A ↗0000914190-26-000169
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F5	M Exercise / conversionRestricted Stock Units · Derivative	3,226D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F4	M Exercise / conversionRestricted Stock Units · Derivative	2,623D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	8,376D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	698D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References: F1	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	22,545D	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	2,019D	72.4	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Geist WilliamOfficer · PRESIDENT, PROTEIN SCIENCES Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,879 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 698 performance RSUs. The remainder of the performance RSUs were forfeited. F4 2,623 restricted stock units vest on 8/15/2027. F5 3,226 restricted stock units vest on each of 8/15/2027 and 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	6,547A	0	Direct	Form 4/A ↗0000914190-26-000170
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F5	M Exercise / conversionRestricted Stock Units · Derivative	4,903D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F4	M Exercise / conversionRestricted Stock Units · Derivative	4,010D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F3	D Other reported codePerformance Restricted Stock Units · Derivative	12,798D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F2, F3	M Exercise / conversionPerformance Restricted Stock Units · Derivative	1,067D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References: F1	D Other reported codePerformance Stock Options (Right to Buy) · Derivative	34,443D	0	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References:	F WithholdingCommon Stock · Non-derivative	4,423D	72.4	Direct	Form 4/A ↗0000914190-26-000171
2026-08-15Filed 2026-11-02Amendment	Hippel JamesOfficer · CFO Filing context Amendment: compare with original; not an additional trade. F1 On 8/15/2026, the Board of Directors authorized discretionary vesting for 2,871 performance options. The remainder of the performance options were forfeited. F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock. F3 On 8/15/2026, the Board of Directors authorized discretionary vesting for 1,067 performance RSUs. The remainder of the performance RSUs were forfeited. F4 4,010 restricted stock units vest on 8/15/2026; and 4,011 restricted stock units vest on 8/15/2027. F5 4,903 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 4,904 restricted stock units vest on 8/15/2028. References:	M Exercise / conversionCommon Stock · Non-derivative	9,980A	0	Direct	Form 4/A ↗0000914190-26-000171

Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.